Abiopharma

News list

Johnson Paula A 🟢 acquired 36.0K shares (1 derivative) of Maze Therapeutics, Inc. (MAZE) at $27.66 Transaction Date: Aug 13, 2026 | Filing ID: 000005

Full text

News bot Aug. 17, 2026, 8:52 p.m.
🔍 Johnson Paula A (Executive)

Company: Maze Therapeutics, Inc. (MAZE)

Report Date: 2026-08-13
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 36,000
Detailed Transactions and Holdings:
- Acquired 36,000 shares of Stock Option (Right to Buy) at $27.665 per share (Derivative)
  Date: 2026-08-13 | Code: A | Expires: 2036-08-12 | equity_swap_involved: 0 | shares_owned_after: 36,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on September 13, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.